| EX1667 OVARIAN CANCER PANEL |
| Specimen: |
4 mL ( 2 mL min.) serum from 1 SST. Ship refrigerated or frozen. |
| Stability: |
| Room |
Refrigerated |
Frozen |
| 2 hrs |
24 hrs |
2 weeks |
|
| Method: |
CMIA, EIA |
| Comment: |
|
| Report: |
Contact us to know the TAT. |
| Usage: |
Ovarian cancer is classified into three types: Epithelial (80%), Germ cell tumor (10-15%) & Stromal sex cord tumors (5-10%). Epithelial ovarian tumors are further subdivided into serious (70%), mucinous(10-15%), and endometroid (10-15%). Granulosa cell tumors represent the majority of the Stromal sex cord tumor. CA 125 is elevated in 50% of patients with stage I ovarian cancer, 90% with stage II and > 90% in stage III & IV. CA 125 is not a good tumor marker for Mucinous & Granulosa cell tumors. Inhibin B is a useful tumor marker for these two malignancies. Inhibin B elevation has been reported in 89-100% of patients with Granulosa cell tumors & 55-60% of patients with Mucinous Epithelial tumors. |
| Doctor Specialty: |
Oncologist |
| Disease: |
Cancer |
| Components: |
*CA 125 *Inhibin B |
| Courier Charges: |
0.00 |
| Home Collection: |
Available (*T&C Apply) |
| Department: |
Biochemistry |
| Pre Test Information: |
No special preparation required |
Reviews
There are no reviews yet.